Yaron M - Search Results

1

The effect of infliximab on extraintestinal manifestations of Crohn's disease.

Kaufman I, Caspi D, Yeshurun D, Dotan I, Yaron M, Elkayam O. Kaufman I, et al. Among authors: yaron m. Rheumatol Int. 2005 Aug;25(6):406-10. doi: 10.1007/s00296-004-0467-8. Epub 2004 Aug 12. Rheumatol Int. 2005. PMID: 15309501 Clinical Trial.

2

Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.

Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D. Elkayam O, et al. Among authors: yaron m. Arthritis Rheum. 2002 Oct;46(10):2571-3. doi: 10.1002/art.10581. Arthritis Rheum. 2002. PMID: 12384913 Free article.

3

Spa therapy for gonarthrosis: a prospective study.

Wigler I, Elkayam O, Paran D, Yaron M. Wigler I, et al. Among authors: yaron m. Rheumatol Int. 1995;15(2):65-8. doi: 10.1007/BF00262710. Rheumatol Int. 1995. PMID: 7481482 Clinical Trial.

4

Long-term experience with low dose methotrexate in rheumatoid arthritis.

Tishler M, Caspi D, Yaron M. Tishler M, et al. Among authors: yaron m. Rheumatol Int. 1993;13(3):103-6. doi: 10.1007/BF00290296. Rheumatol Int. 1993. PMID: 8235288

5

Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis.

Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D. Elkayam O, et al. Among authors: yaron i, yaron m. Rheumatol Int. 2000;19(3):101-5. doi: 10.1007/s002960050111. Rheumatol Int. 2000. PMID: 10776688

6

Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution.

Elkayam O, Ophir J, Yaron M, Caspi D. Elkayam O, et al. Among authors: yaron m. Clin Rheumatol. 2000;19(4):301-5. doi: 10.1007/pl00011173. Clin Rheumatol. 2000. PMID: 10941813

7

Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease.

Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M. Caspi D, et al. Among authors: yaron m. Rheumatol Int. 2001 Feb;20(2):43-7. doi: 10.1007/s002960000073. Rheumatol Int. 2001. PMID: 11269531

8

Abdominal scintigraphy using technetium Tc 99m hexylmethylpropylene amine oxime-labeled leukocytes in patients with seronegative spondyloarthropathies.

Elkayam O, Paran D, Even-Sapir E, Litinsky I, Wigler I, Yaron M, Caspi D. Elkayam O, et al. Among authors: yaron m. Semin Arthritis Rheum. 2002 Jun;31(6):406-12. doi: 10.1053/sarh.2002.32550. Semin Arthritis Rheum. 2002. PMID: 12077713

9

Somatostatin analogue treatment attenuates histological findings of inflammation and increases mRNA expression of interleukin-1 beta in the articular tissues of rats with ongoing adjuvant-induced arthritis.

Paran D, Kidron D, Mayo A, Ziv O, Chowers Y, Caspi D, Yaron M, Paran H. Paran D, et al. Among authors: yaron m. Rheumatol Int. 2005 Jun;25(5):350-6. doi: 10.1007/s00296-004-0455-z. Epub 2004 Mar 26. Rheumatol Int. 2005. PMID: 15045524

10

The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis.

Litinsky I, Paran D, Levartovsky D, Wigler I, Kaufman I, Yaron I, Yaron M, Caspi D, Elkayam O. Litinsky I, et al. Among authors: yaron i, yaron m. Cytokine. 2006 Jan 21;33(2):106-10. doi: 10.1016/j.cyto.2005.12.009. Epub 2006 Feb 17. Cytokine. 2006. PMID: 16487722 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters